Multiple Sclerosis

Study finds link between autoimmune skin disease and several neurologic disorders, including dementia, MS, epilepsy, and Parkinson's disease.

Successfully treating and reversing the effects of multiple sclerosis may one day be possible using a drug originally developed to treat chronic pain.

Mindfulness meditation can improve fatigue, depression, and other measure of quality of life in patietns with multiple sclerosis.

Until just a few years ago, neurologists could only observe as MS ravaged the nervous systems of our patients. The therapies available were basically symptomatic, and didn't really alter prognosis. The advent of disease modifying therapies (DMT) made a big difference: These immune system modifying agents slowed the progression of MS and improved quality of life for many patients.

We've collected links to some of the top podcast resources for primary care physicians.

Some neurologic disorders increase the risk of problematic outcomes of pregnancy. Data on such associations have been scant, but this is beginning to change. For example, with regard to epilepsy, there are a number of pregnancy registries which track outcomes related to antiepileptic drug therapy. However, large trials and population studies are not common.

Tysabri (natalizumab) is a monoclonal antibody, which is an effective treatment for relapsing forms of MS. However, it can cause progressive multifocal leukoencephalopathy.

Systemic sclerosis (SSc), or scleroderma, is a condition of connective tissue characterized by inflammation and fibrosis of the skin and internal organs. The disease is rare but associated with significant morbidity and mortality.

Research has shown that multiple sclerosis (MS) is "the most common cause of neurological disability in young adults."